CJC-1295 (Without DAC) – 5 mL + IPA 5 mL
CJC-1295 (Without DAC) is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), developed for research into endocrine signaling and growth hormone regulation. Unlike the DAC-modified version, this form is designed to reflect a shorter activity profile that more closely resembles natural GHRH behavior in biological systems.
In research environments, CJC-1295 (Without DAC) is studied for its selective interaction with GHRH receptors located in the pituitary axis. These receptors regulate pulsatile growth hormone signaling, making the peptide valuable for examining natural hormone rhythm and feedback mechanisms.
One of the defining characteristics of CJC-1295 without DAC is its rapid clearance compared to long-acting analogs. This allows researchers to investigate acute signaling responses and short-term endocrine dynamics rather than sustained hormonal elevation.
CJC-1295 (Without DAC) is frequently included in studies focused on growth hormone pulse timing and amplitude. Understanding how brief receptor activation influences downstream signaling is a key area of interest in endocrine research.
The peptide is also examined in metabolic signaling research. Growth hormone pathways are closely tied to lipid utilization, protein metabolism, and energy balance, making CJC-1295 relevant for controlled metabolic studies.
Unlike direct growth hormone analogs, CJC-1295 works by stimulating endogenous signaling pathways rather than replacing the hormone itself. This distinction allows researchers to study physiological regulation while maintaining natural feedback loops.
Researchers often use the non-DAC form to compare signaling differences between short-acting and long-acting GHRH analogs. These comparisons help clarify how peptide structure influences duration and intensity of receptor activation.
CJC-1295 (Without DAC) is also studied in gene expression research, where growth hormone–related transcriptional changes are examined following transient signaling events.
The inclusion of IPA (Isopropyl Alcohol) in research kits supports laboratory handling and preparation protocols under controlled conditions. Its presence is intended strictly for research and laboratory use.
The peptide’s predictable molecular behavior supports reproducibility in experimental settings. Consistent receptor interaction allows for reliable comparison across studies.
CJC-1295 (Without DAC) is commonly included in endocrine research that prioritizes physiological accuracy over prolonged stimulation. This makes it useful for studies focused on natural hormonal signaling patterns.
Because growth hormone signaling affects multiple tissues, the peptide is often used in systems-based research rather than isolated pathway analysis.
Its well-characterized structure and short-acting profile make CJC-1295 (Without DAC) a valuable reference compound in growth hormone research.
As interest in peptide-based endocrine investigation continues to expand, CJC-1295 (Without DAC) remains an important tool for studying regulated growth hormone signaling within complex biological systems.
New
CJC-1295 without DAC 5ml + IPA 5ml
$90.00
CJC-1295 (Without DAC) is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), developed for research into endocrine signaling and growth hormone regulation. Unlike the DAC-modified version, this form is designed to reflect a shorter activity profile that more closely resembles natural GHRH behavior in biological systems.
Description
Shipping & Delivery
Related products
5-Amino-1MQ 50mg (60 Capsules)
5-amino-1MQ is a small molecule that blocks the activity of the enzyme called nicotinamide N-methyltransferase (NNMT). NNMT is a very important component in metabolism and energy and is predominantly active in fat tissue. By blocking NNMT, 5-amino-1MQ stimulates an increase in nicotinamide adenine dinucleotide (NAD+), a cofactor that is central to cellular metabolism, thereby increasing metabolic rate and activating a gene called sirtuin-1 (SIRT1).
SIRT1 is also known as the "longevity gene" because of its role in reducing the risk of diabetes, obesity, metabolic syndrome, atherosclerosis and other forms of cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer. Research in mice given 5-amino-1MQ showed a 7% reduction in body mass over 10 days without any changes in food intake, compared to controls. Research has shown that decreasing NNMT may help shrink fat cells and reduce the size of fat deposits. 
BPC-157 10mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. BPC-157 5mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. BPC-157 5mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
Semaglutide 10
Semaglutide is a widely researched peptide-based compound recognized for its significant role in metabolic regulation and appetite control. It belongs to the class of GLP-1 receptor agonists, which are designed to mimic naturally occurring hormones involved in glucose metabolism and satiety signaling.
Tesamorelin, Ipamorelin 8mg (Blend)
The scientific community continues to explore new applications for Ipamorelin, particularly in regenerative biology, metabolic optimization, and long-term health research. As understanding of GH and IGF-1 pathways deepens, Ipamorelin remains a cornerstone tool for investigating the body’s natural growth and repair mechanisms.
Reviews
There are no reviews yet.